Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Coronary artery revascularisation: selecting the appropriate strategy.

Adams MR.

Intern Med J. 2013 Jan;43(1):18-22. doi: 10.1111/imj.12020. Review.

PMID:
23324088
2.

Drug-eluting coronary stents: many meta-analyses, little benefit.

[No authors listed]

Prescrire Int. 2009 Apr;18(100):70-4.

PMID:
19585727
3.
4.

Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.

Li Y, Zheng Z, Xu B, Zhang S, Li W, Gao R, Hu S.

Circulation. 2009 Apr 21;119(15):2040-50. doi: 10.1161/CIRCULATIONAHA.108.819730. Epub 2009 Apr 6.

5.

Coronary artery stents: a rapid systematic review and economic evaluation.

Hill R, Bagust A, Bakhai A, Dickson R, Dündar Y, Haycox A, Mujica Mota R, Reaney A, Roberts D, Williamson P, Walley T.

Health Technol Assess. 2004 Sep;8(35):iii-iv, 1-242. Review.

6.

DES the year in review: controversies.

Garg S, Bourantas C, Serruys PW.

Minerva Cardioangiol. 2013 Apr;61(2):99-123. Review.

PMID:
23492595
7.
8.

Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.

Yi G, Youn YN, Yoo KJ, Hong YS.

Ann Thorac Surg. 2008 Nov;86(5):1438-43. doi: 10.1016/j.athoracsur.2008.07.040.

PMID:
19049727
9.

Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.

Agema WR, Monraats PS, Zwinderman AH, De Winter RJ, Tio RA, Doevendans PA, Waltenberger J, De Maat MP, Frants RR, Atsma DE, Van Der Laarse A, Van Der Wall EE, Jukema JW.

Eur Heart J. 2004 Jul;25(13):1163-70.

PMID:
15231375
10.

Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of early outcomes from randomized and nonrandomized studies.

Cao C, Manganas C, Bannon P, Vallely M, Yan TD.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):738-47. doi: 10.1016/j.jtcvs.2012.02.004. Epub 2012 Mar 9.

11.

Drug-eluting stents and the future of coronary artery bypass surgery: facts and fiction.

Raja SG.

Ann Thorac Surg. 2006 Mar;81(3):1162-71. Review.

PMID:
16488758
12.

Hybrid coronary revascularization in the era of drug-eluting stents.

Murphy GJ, Bryan AJ, Angelini GD.

Ann Thorac Surg. 2004 Nov;78(5):1861-7. Review.

PMID:
15511503
13.

Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.

Lima VC, Mattos LA, Caramori PR, Perin MA, Mangione JA, Machado BM, Coelho WM, Bueno RR.

Arq Bras Cardiol. 2006 Oct;87(4):e162-7. Review. English, Portuguese.

14.

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.

J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077.

15.

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A.

Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29. No abstract available.

PMID:
25173339
16.

Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS, Carlson RE, Jones RH.

N Engl J Med. 2008 Jan 24;358(4):331-41. doi: 10.1056/NEJMoa071804.

17.

[Revascularisation of unprotected left main coronary artery disease: an update].

Eltchaninoff H, Tron C, Brunet D, Baala B, Cribier A.

Arch Mal Coeur Vaiss. 2007 Mar;100(3):207-11. Review. French.

PMID:
17536424
19.

Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.

Kappetein AP, Dawkins KD, Mohr FW, Morice MC, Mack MJ, Russell ME, Pomar J, Serruys PW.

Eur J Cardiothorac Surg. 2006 Apr;29(4):486-91. Epub 2006 Feb 23.

PMID:
16497510
20.

Supplemental Content

Support Center